Skip to main content
OpenTrials
Completed

NCT Number: NCT03337425

Psychoeducational Groups for Adults With ADHD

This pilot study aims to assess patient satisfaction and preliminary efficacy of a psychoeducational group treatment, using a randomized waitlist-controlled trial, at two different outpatient clinics in mid-Norway. All participants will receive standard treatment during the intervention period. Assessment of client satisfaction (CSQ 8), general self-efficacy (GSE-6), ADHD-related quality of life (AAQoL) symptoms of ADHD (SCL-9; ASRS), and work participation will be conducted at time of recruitment prior to randomization (T0), pre- (T1), post-treatment (T2), with a 10 week follow-up.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Attention Deficit Hyperactivity Disorder Attention Deficit Disorder with Hyperactivity Attention Deficit and Disruptive Behavior Disorders Mental Disorders Neurodevelopmental Disorders

Age range

18 year–67 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, N-T, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • confirmed ADHD diagnosis
  • speaking a Scandinavian language

Exclusion criteria

  • not able or willing to give informed consent
  • psychosis
  • severe learning difficulties

Treatment and study plan

Psychoeducational group therapy

Behavioral

The group-based psychoeducational program consists of 10 sessions, run over 10 consecutive weeks. Each session consist of a lecture, given by a recruited expert on the topic of the session (20 minutes) with a following discussion of the topic (45 minutes), facilitated by the course leader. All sessions are organized and led by the course leader, which also includes keeping structure in time, discussion and closing of the session. Psychoeducation comes in addition to standard treatment (ADHD treatment as usual).

Waiting list

Behavioral

Waiting list and standard treatment (ADHD treatment as usual)

standard treatment

Other

Standard treatment consists of diagnostic assessment of ADHD and comorbidity, as well as treatment with medication. In addition, some patients receive cognitive behavioral therapy, although this is not systematically given to every patient. If needed, patients are also offered assistance with regard to economy, housing, education and work. As well as contact with family and network.

Other names: Treatment as usual

Primary outcomes

  1. Change in patient satisfaction

    Time frame: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

    Measured with a modified version of the Client Satisfaction Questionnaire (CSQ-8). The scale consists of 8 items measured on a scale from 1 to 4. A sum score between 8 and 32 indicate the level of satisfaction with services provided.

  2. Change in general self-efficacy

    Time frame: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

    Measured with General Self-Efficacy Scale (GSE-6), a short-form measure of self-efficacy. Self-efficacy is regarded as a protective factor in adapting to stress and chronic illness. The scale consists of 6 items, measured on a 4-point scale, with a possible range of 6-24.

Secondary outcomes

  1. Change in ADHD-related symptoms (ASRS)

    Time frame: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

    Measured with ASRS, a self-reporting scale for ADHD-related symptoms in adults. The scale consists of 18 items, based on DSM-V diagnostic criteria for ADHD. The items are measured on a 5-point scale, with a possible range of 0-72.

  2. Change in ADHD-related symptoms (SCL-9)

    Time frame: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

    Measured with 9 items from the SCL-90. SCL-9 is an ADHD-specific scale, consisting of 9 items of the original 90. SCL-9 covers the specific characteristic traits of ADHD.

  3. Change in ADHD-related quality of life

    Time frame: Baseline, post-intervention (10 weeks) and after 10 weeks follow-up (20 weeks)

    Measured with AAQoL - which covers ADHD-specific quality of life and function. AAQoL consists of 29 questions measuring health related quality of life among adults with ADHD.

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • Helse Nord-Trøndelag HF

Registry information

Official study title

Psychoeducational Groups for Adults With Attention-Deficit Hyperactivity/Impulsivity Disorder (ADHD): a Randomized Waitlist-controlled Multicenter Pilot Trial

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Nov 9, 2017
Registry last updated
Jul 16, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.